News Releases

Parasiticide Treatment for Dogs Offers Unrivaled Duration of Flea and Tick Protection Compared to Existing Products Rahway, N.J., February 11, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that S&P Global Animal Health awarded the injectable formulation of BRAVECTO® (fluralaner) the 2024 Best New Companion […]

Read more

RAHWAY, N.J., Jan. 30, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that Laurie Hueneke Martens, associate vice president, Global Public Policy and Government Relations, was awarded the 8th Annual Feather in Her Cap Award from the Feather in Her Cap Association. Hueneke was recognized […]

Read more

The new formulation targets internal and external parasites, expanding the BRAVECTO® portfolio Rahway, NJ, – November 26, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has granted the marketing authorization for BRAVECTO® TriUNO, a new formulation of BRAVECTO (fluralaner) for dogs that targets […]

Read more

Vaccine can now be administered intramuscularly or through subcutaneous injection as well as at the same time as BOVILIS® CRYPTIUM® Subcutaneous injections are generally well-tolerated by animals, can minimize pain and distress, and improve meat quality[i] Rahway, N.J., October 15, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA […]

Read more

RAHWAY, N.J., August 29, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than six million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. “Many communities where rabies outbreaks persist, have limited access to resources and vaccines,” said Ingrid Deuzeman, […]

Read more

New vaccine protects against two of the most common swine diseases, while offering animal-friendly and efficient administration through IDAL® device technology Rahway, NJ, Sept. 25, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the  European Medicines Agency has granted the marketing authorization in the […]

Read more

Innovative technology represents a breakthrough scientific achievement for one of the most common feline infectious diseases RAHWAY, N.J., September 24, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the expansion of the newly USDA-approved NOBIVAC® NXT vaccine platform to include a best in class solution […]

Read more

Launch coincides with new updates to SenseHub Ecosystem and SenseHub Dairy aimed at increasing capabilities and efficiencies for herds of all size Rahway, NJ. August 09, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the availability of SenseHub™ Dairy Youngstock for preweaned calves in individual […]

Read more